PubMed

FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors.

Carracedo A, Egervari K, Salido M, Rojo F, Corominas JM, Arumi M, Corzo C, Tusquets I, Espinet B, Rovira A, Albanell J, Szollosi Z, Serrano S, Solé F.

Breast Cancer Res. 2009;11(2):402. Epub 2009 Apr 21. No abstract available. PMID: 19439036 [PubMed - indexed for MEDLINE]Related articlesFree article

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

Breast Cancer Res. 2009;11(1):R11. Epub 2009 Feb 24.PMID: 19239686 [PubMed - indexed for MEDLINE]Related articlesFree article

Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.

de Candia P, Akram M, Benezra R, Brogi E.

Hum Pathol. 2006 Aug;37(8):1032-41. Epub 2006 May 22.PMID: 16867866 [PubMed - indexed for MEDLINE]Related articles

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.

Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA.

J Clin Oncol. 2008 May 20;26(15):2473-81. Erratum in: J Clin Oncol. 2008 Jul 10;26(20):3472. Perez, Edith D [corrected to Perez, Edith A]. PMID: 18487567 [PubMed - indexed for MEDLINE]Related articles

Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.

Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P.

Hum Pathol. 2008 Dec;39(12):1809-15. Epub 2008 Aug 19.PMID: 18715613 [PubMed - indexed for MEDLINE]Related articles

Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.

Chen C, Zhou Z, Sheehan CE, Slodkowska E, Sheehan CB, Boguniewicz A, Ross JS.

Int J Cancer. 2009 Jun 15;124(12):2829-36.PMID: 19267401 [PubMed - indexed for MEDLINE]Related articles

Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast.

Bock N, Meden H, Regenbrecht M, Jünemann B, Wangerin J, Marx D.

Anticancer Res. 2000 Jan-Feb;20(1A):119-24.PMID: 10769643 [PubMed - indexed for MEDLINE]Related articles

Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.

Webster LR, Lee SF, Ringland C, Morey AL, Hanby AM, Morgan G, Byth K, Mote PA, Provan PJ, Ellis IO, Green AR, Lamoury G, Ravdin P, Clarke CL, Ward RL, Balleine RL, Hawkins NJ.

Clin Cancer Res. 2008 Oct 15;14(20):6625-33.PMID: 18927304 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunohistochemical analysis of prostate specific antigen in breast cancer.

Miller MK, Unger PD, Bleiweiss IJ.

Breast Cancer Res Treat. 2001 Jul;68(2):111-6.PMID: 11688514 [PubMed - indexed for MEDLINE]Related articles

[Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer]

Mchedlishvili MIu, Gabunia UA, Makharoblidze ER, Burnadze KT, Piradashvili DZ.

Georgian Med News. 2005 Feb;(119):65-7. Russian. PMID: 15834186 [PubMed - indexed for MEDLINE]Related articles

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.

Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA.

Breast Cancer Res. 2008;10(5):R85. Epub 2008 Oct 15. Erratum in: Breast Cancer Res. 2009;11(1):401. PMID: 18922159 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry.

Tafjord S, Bøhler PJ, Risberg B, Torlakovic E.

Diagn Cytopathol. 2002 Mar;26(3):137-41.PMID: 11892015 [PubMed - indexed for MEDLINE]Related articles

Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer.

Turashvili G, Bouchalova K, Bouchal J, Kolar Z.

Cesk Patol. 2007 Jul;43(3):87-92.PMID: 17821836 [PubMed - indexed for MEDLINE]Related articles

Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.

Matteucci E, Bendinelli P, Desiderio MA.

Carcinogenesis. 2009 Jun;30(6):937-45. Epub 2009 Apr 8.PMID: 19357348 [PubMed - indexed for MEDLINE]Related articles

Expression and prognostic value of L1-CAM in breast cancer.

Schröder C, Schumacher U, Fogel M, Feuerhake F, Müller V, Wirtz RM, Altevogt P, Krenkel S, Jänicke F, Milde-Langosch K.

Oncol Rep. 2009 Nov;22(5):1109-17.PMID: 19787228 [PubMed - indexed for MEDLINE]Related articles

Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.

Chen T, Jackson CR, Link A, Markey MP, Colligan BM, Douglass LE, Pemberton JO, Deddens JA, Graff JR, Carter JH.

Clin Cancer Res. 2006 Jan 15;12(2):392-7.PMID: 16428477 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of tight junction protein claudin-4 in basal-like breast carcinomas.

Kulka J, Szász AM, Németh Z, Madaras L, Schaff Z, Molnár IA, Tokés AM.

Pathol Oncol Res. 2009 Mar;15(1):59-64. Epub 2008 Aug 28.PMID: 18752049 [PubMed - indexed for MEDLINE]Related articles

Stage-related plasma values of transforming growth factor-beta1 are steroid receptors dependent.

Todorović-Raković N, Nesković-Konstantinović Z, Nikolić-Vukosavljević D.

Clin Exp Med. 2009 Dec;9(4):313-7. Epub 2009 May 21.PMID: 19458909 [PubMed - indexed for MEDLINE]Related articles

Menopausal hormone therapy and risk of clinical breast cancer subtypes.

Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. Epub 2009 Mar 31.PMID: 19336542 [PubMed - indexed for MEDLINE]Related articles

RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.

Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M.

Pathol Res Pract. 2009;205(6):403-8. Epub 2009 Feb 20.PMID: 19232840 [PubMed - indexed for MEDLINE]Related articles